In type 2 diabetes, the issue with GLP-1 is not usually that the body makes too little of it, but rather: 1
Stephen Provencher, Oakville, ON, CA) on a short echo time single-voxel 1H MRS in parieto/occipital grey matter and parietal white matter on a 3 Tesla General Electric magnet prior to starting the ketogenic diet and at 6 months
These data confirmed the inhibition activity of the selected products
The SURMOUNT-1 DXA substudy (Look et al., 2025) showed that tirzepatide reduced lean body mass by 10.9% over 72 weeks, compared to 2.6% with placebo
However, the medication does not specifically target sugar receptors or create an aversion to sweet foods through a direct pharmacological mechanism
With the injection of BPC 157 comes the increased production of nitric oxide (NO), which is essential for many bodily processes